The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Open accessAbstract
BACKGROUND: Endometriosis is a risk factor for epithelial ovarian cancer; however, whether this risk extends to all invasive histological subtypes or borderline tumours is not clear. We undertook an international collaborative study to assess the association between endometriosis and histological subtypes of ovarian cancer. METHODS: Data from 13 ovarian cancer case-control studies, which were part of the Ovarian Cancer Association Consortium, were pooled and logistic regression analyses were undertaken to assess the association between self-reported endometriosis and risk of ovarian cancer. Analyses of invasive cases were done with respect to histological subtypes, grade, and stage, and analyses of borderline tumours by histological subtype. Age, ethnic origin, study site, parity, and duration of oral contraceptive use were included in all analytical models. FINDINGS: 13 226 controls and 7911 women with invasive ovarian cancer were included in this analysis. 818 and 738, respectively, reported a history of endometriosis. 1907 women with borderline ovarian cancer were also included in the analysis, and 168 of these reported a history of endometriosis. Self-reported endometriosis was associated with a significantly increased risk of clear-cell (136 [20·2%] of 674 cases vs 818 [6·2%] of 13 226 controls, odds ratio 3·05, 95% CI 2·43-3·84, p<0·0001), low-grade serous (31 [9·2%] of 336 cases, 2·11, 1·39-3·20, p<0·0001), and endometrioid invasive ovarian cancers (169 [13·9%] of 1220 cases, 2·04, 1·67-2·48, p<0·0001). No association was noted between endometriosis and risk of mucinous (31 [6·0%] of 516 cases, 1·02, 0·69-1·50, p=0·93) or high-grade serous invasive ovarian cancer (261 [7·1%] of 3659 cases, 1·13, 0·97-1·32, p=0·13), or borderline tumours of either subtype (serous 103 [9·0%] of 1140 cases, 1·20, 0·95-1·52, p=0·12, and mucinous 65 [8·5%] of 767 cases, 1·12, 0·84-1·48, p=0·45). INTERPRETATION: Clinicians should be aware of the increased risk of specific subtypes of ovarian cancer in women with endometriosis. Future efforts should focus on understanding the mechanisms that might lead to malignant transformation of endometriosis so as to help identify subsets of women at increased risk of ovarian cancer. FUNDING: Ovarian Cancer Research Fund, National Institutes of Health, California Cancer Research Program, California Department of Health Services, Lon V Smith Foundation, European Community's Seventh Framework Programme, German Federal Ministry of Education and Research of Germany, Programme of Clinical Biomedical Research, German Cancer Research Centre, Eve Appeal, Oak Foundation, UK National Institute of Health Research, National Health and Medical Research Council of Australia, US Army Medical Research and Materiel Command, Cancer Council Tasmania, Cancer Foundation of Western Australia, Mermaid 1, Danish Cancer Society, and Roswell Park Alliance Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“endometrioid cancer (OR 2.21)”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“It is becoming clear that epigenetics and genomic instability associated with the particular microenvironment of endometriosis characterized by oxidative stress, inflammatory process and high estrogen levels contribute to the process of malignant transformation of endometriosis (Pearce et al., 2012, Nezhat et al., 2014).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al., 2012
In the citing paper
“and low-grade serous invasive ovarian cancers (OR 2.21).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. (2012), concluded that self-reported endometriosis was associated with significantly increased risk for CCC [odds ratio (OR) 3.05]”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. summarized 13 case-control studies and reported the highest odds ratio of 3.05 for clear cell carcinoma, followed by LG-serous (2.11) and endometrioid carcinoma (2.04) in patients with endometriosis [9].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Malignant transformation of ovarian endometriosis has been well documented.”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“In population-based studies, the incidence of ovarian cancer in patients with a history of ovarian endometriosis is 1.35-1.49times greater compared with those without this history [9,10].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Of these, we observed associations with multiple diseases or traits, including epithelial ovarian cancer21, low-density lipoprotein cholesterol22, coronary heart disease23, luteinizing hormone and follicle-stimulating hormone levels, and age at onset for menopause24.”
From Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism (2017) · cites this paper as [21]
In the citing paper
“Most recently, in a study of 13 226 controls and 7911 women with invasive ovarian cancer, self-reported endometriosis was associated with a significantly increased risk of clear-cell, low-grade serous, and endometrioid invasive ovarian cancers.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“No association was noted between endometriosis and risk of mucinous or high-grade serous invasive ovarian cancer or borderline tumors of either subtype.118”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“Endometriosis and ovarian cancer have been linked by a number of studies.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“which have been (suggested to be) associated with endometriosis or its constituting symptoms in epidemiologic studies (51–54).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,890
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Self-citationEskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
Kurman, R. J., & Shih, I. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.03.003 · Cited by 1,099
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Bradburn, M. J., Deeks, J. J., Berlin, J. A., & Russell Localio, A. (2007) · Statistics in Medicine · doi:10.1002/sim.2528 · Cited by 938
Ovarian Tumors in a Cohort of Infertile Women
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311204 · Cited by 721
Self-citationCancer risk after a hospital discharge diagnosis of endometriosis
Brinton, L. A., Gridley, G., Persson, I. R., Baron, J. A., & Bergqvist, A. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70550-7 · Cited by 549
Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies
Ness, R. B. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.3.217 · Cited by 425
Self-citationRisk of cancer after use of fertility drugs with in-vitro fertilisation
Venn, A., Watson, L., Bruinsma, F., Giles, G. G., & Healy, D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05203-4 · Cited by 368
Endometriosis and the risk of cancer with special emphasis on ovarian cancer
Melin, A., Sparén, P., Persson, I., & Bergqvist, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei462 · Cited by 306
Cited by
Sorted by citations
Items 201–300 of 946
The Endometriotic Tumor Microenvironment in Ovarian Cancer
Wendel, J. R. H., Wang, X., & Hawkins, S. M. (2018) · Cancers · doi:10.3390/cancers10080261 · Cited by 51
Endometriosis-associated Ovarian Clear Cell Carcinoma: A Special Entity?
Sun, Y., & Liu, G. (2021) · Journal of Cancer · doi:10.7150/jca.61107 · Cited by 52
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk
Lee, A. W., Ness, R. B., Roman, L. D., Terry, K. L., Schildkraut, J. M., Chang-Claude, J., Doherty, J. A., Menon, U., Cramer, D. W., Gayther, S. A., et al. (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001387 · Cited by 51
Self-citationClear cell carcinomas of the ovary and kidney: clarity through genomics
Ji, J. X. Y., Wang, Y. K., Cochrane, D. R., & Huntsman, D. D. (2018) · The Journal of Pathology · doi:10.1002/path.5037 · Cited by 52
Self-citationClear cell carcinoma of the ovary
Tang, H., Liu, Y., Wang, X., Guan, L., Chen, W., Jiang, H., & Lu, Y. (2018) · Medicine · doi:10.1097/md.0000000000010881 · Cited by 51
Park, J., Suh, D., Kim, J.-H., Kim, Y., Kim, Y., & Nam, J. (2016) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2015.10.022 · Cited by 50
Schildkraut, J. M., Abbott, S. E., Alberg, A. J., Bandera, E. V., Barnholtz‐Sloan, J. S., Bondy, M. L., Coté, M. L., Funkhouser, E. M., Peres, L. C., Peters, E. S., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1281 · Cited by 50
Self-citationPaik, E. S., Kim, T., Choi, C. H., Kim, B., Bae, D., & Lee, J. (2017) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2018.29.e18 · Cited by 49
Guideline No. 403: Initial Investigation and Management of Adnexal Masses
Salvador, S. C., Scott, S., Glanc, P., Eiriksson, L. R., Jang, J.-H., Sebastianelli, A., & Dean, E. A. (2020) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.08.044 · Cited by 49
Risk Factors for Ovarian Cancer: An Umbrella Review of the Literature
Whelan, E., Kalliala, I. E. J., Semertzidou, A., Raglan, O., Bowden, S. J., Kechagias, K. S., Markozannes, G., Cividini, S., McNeish, I. A., Marchesi, J. R., et al. (2022) · Cancers · doi:10.3390/cancers14112708 · Cited by 52
Ye, S., Yang, J., You, Y., Cao, D., Bai, H., Lang, J., Chen, J., & Shen, K. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.08.008 · Cited by 50
Dietary and Nutritional Interventions for the Management of Endometriosis
Abulughod, N., Valakas, S., & El‐Assaad, F. (2024) · Nutrients · doi:10.3390/nu16233988 · Cited by 55
Novel three-dimensional in vitro models of ovarian endometriosis
Brueggmann, D., Templeman, C. E., Starzinski‐Powitz, A., Rao, N. P., Gayther, S. A., & Lawrenson, K. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-17 · Cited by 48
Self-citationHeckl, M., Schmoeckel, E., Hertlein, L., Rottmann, M., Jeschke, U., & Mayr, D. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192881 · Cited by 48
Co-existence of leiomyomas, adenomyosis and endometriosis in women with endometrial cancer
Johnatty, S. E., Stewart, C. J. R., Smith, D. S., Nguyen, A. N., Dwyer, J. O., O’Mara, T. A., Webb, P. M., & Spurdle, A. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-59916-1 · Cited by 48
Self-citationEarly pregnancy sex steroids and maternal risk of epithelial ovarian cancer
Schöck, H., Surcel, H., Zeleniuch‐Jacquotte, A., Grankvist, K., Lakso, H., Fortner, R. T., Kaaks, R., Pukkala, ., Lehtinen, M., Toniolo, P. G., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0282 · Cited by 47
Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways
Kane, M. A., Sidell, N., & Taylor, R. N. (2015) · Seminars in Reproductive Medicine · doi:10.1055/s-0035-1554920 · Cited by 47
Cannioto, R. A., LaMonte, M. J., Risch, H. A., Hong, C., Sucheston-Campbell, L. E., Eng, K. H., Szender, J. B., Chang‐Claude, J., Schmalfeldt, B., Klapdor, R., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1330 · Cited by 47
Self-citationNakaoka, H., Gurumurthy, A., Hayano, T., Ahmadloo, S., Omer, W. H., Yoshihara, K., Yamamoto, A., Kurose, K., Enomoto, T., Akira, S., et al. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1005893 · Cited by 46
Moss, E. L., Taylor, A., Andreou, A., Ang, C., Arora, R., Attygalle, A. D., Banerjee, S. N., Bowen, R. L., Buckley, L., Burbos, N., et al. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.06.025 · Cited by 49
Clear Cell Carcinoma of Ovary and Uterus
Glasspool, R. M., & McNeish, I. A. (2013) · Current Oncology Reports · doi:10.1007/s11912-013-0346-0 · Cited by 47
Kar, S., Berchuck, A., Gayther, S. A., Goode, E. L., Moysich, K. B., Pearce, C. L., Ramus, S. J., Schildkraut, J. M., Sellers, T. A., & Pharoah, P. D. P. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0315 · Cited by 49
Self-citationYeh, C., Su, F., Tzeng, C., Muo, C., & Wang, W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194011 · Cited by 46
Gandini, S., Lazzeroni, M., Peccatori, F. A., Bendinelli, B., Saieva, C., Palli, D., Masala, G., & Caini, S. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.12.009 · Cited by 46
Ñiguez, I., Linde, F. M., Sánchez, M. D. P. M., Arense, J. J., Torroba, A., Díaz, A. N., & Sánchez-Ferrer, M. L. (2019) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2019.30.e63 · Cited by 47
Yachida, N., Yoshihara, K., Yamaguchi, M., Suda, K., Tamura, R., & Enomoto, T. (2021) · Cancers · doi:10.3390/cancers13061439 · Cited by 48
A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer
Chen, S., Li, Y., Qian, L., Deng, S., Liu, L., Xiao, W., & Zhou, Y. Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.668151 · Cited by 47
Ose, J., Fortner, R. T., Rinaldi, S., Schöck, H., Overvad, K., Tjønneland, A. M., Hansen, L., Dossus, L., Fournier, A., Baglietto, L., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29000 · Cited by 47
An Update on Surgical versus Expectant Management of Ovarian Endometriomas in Infertile Women
Keyhan, S., Hughes, C. L., Price, T. M., & Muasher, S. J. (2015) · BioMed Research International · doi:10.1155/2015/204792 · Cited by 46
Tian, X., Xu, L., & Wang, P. (2015) · PubMed Central · Cited by 45
Machida, H., Maeda, M., Cahoon, S. S., Scannell, C. A., Garcia‐Sayre, J., Roman, L. D., & Matsuo, K. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4375-z · Cited by 46
Dietary fat intake and risk of epithelial ovarian cancer by tumour histology
Merritt, M. A., Cramer, D. W., Missmer, S. A., Vitonis, A. F., Titus, L. J., & Terry, K. L. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.16 · Cited by 45
Self-citationCoetzee, S. G., Shen, H. C., Hazelett, D. J., Lawrenson, K., Kuchenbaecker, K. B., Tyrer, J. P., Rhie, S. K., Levanon, K., Karst, A. M., Drapkin, R., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv101 · Cited by 44
Self-citationGaudet, M. M., Gapstur, S. M., Sun, J., Teras, L. R., Campbell, P. T., & Patel, A. V. (2014) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000270 · Cited by 44
New knowledge and insights about the malignant transformation of endometriosis
Taniguchi, F. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13372 · Cited by 45
Coan, M., Vinciguerra, G. L. R., Cesaratto, L., Gardenal, E., Bianchet, R., Dassi, E., Vecchione, A. M., Baldassarre, G., Spizzo, R., & Nicoloso, M. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092512 · Cited by 46
Rogers‐Broadway, K., Kumar, J., Sisu, C., Wander, G., Mazey, E., Jeyaneethi, J., Pados, G., Tsolakidis, D., Klonos, E., Grunt, T. W., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3967 · Cited by 44
Pathophysiology and Clinical Implications of Ovarian Endometriomas
Nezhat, F. R., Cathcart, A. M., NEZHAT, C. H., & NEZHAT, C. R. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005587 · Cited by 43
Morphological and molecular heterogeneity of epithelial ovarian cancer: Therapeutic implications
Romero, I., Leskelä, S., Perez‐Mies, B., Poveda, A. M., & Palacios, J. (2020) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2020.02.001 · Cited by 46
Backonja, U., Hediger, M. L., Chen, Z., Lauver, D., Sun, L., Peterson, C. M., & Louis, G. M. B. (2017) · Journal of Women s Health · doi:10.1089/jwh.2016.6128 · Cited by 43
Borghese, B., Santulli, P., Marcellin, L., & Chapron, C. (2018) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2018.02.017 · Cited by 47
Identification of Immune-Related Key Genes in Ovarian Cancer Based on WGCNA
Quan, Q., Xiong, X., Wu, S., & Yu, M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.760225 · Cited by 41
Yang, H., Meeker, A. K., Guido, R. S., Gunter, M. J., Huang, G. S., Luhn, P., D’Ambrosio, L., Wentzensen, N., & Sherman, M. E. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0666-5 · Cited by 41
Wang, S., Qiu, L., Lang, J. H., Shen, K., Huang, H. F., Pan, L. Y., Wu, M. P., Yang, J. X., & Guo, L. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.05.032 · Cited by 41
Novel Glycobiomarker for Ovarian Cancer That Detects Clear Cell Carcinoma
Sogabe, M., Nozaki, H., Tanaka, N., Kubota, T., Kaji, H., Kuno, A., Togayachi, A., Gotoh, M., Nakanishi, H., Nakanishi, T., et al. (2014) · Journal of Proteome Research · doi:10.1021/pr401109n · Cited by 41
Association between endometriosis and gynecological cancers: a critical review of the literature
Kalaitzopoulos, D. R., Mitsopoulou, A., Iliopoulou, S. M., Daniilidis, A., Samartzis, E. P., & Economopoulos, K. P. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05445-1 · Cited by 41
Ferroptosis resistance mechanisms in endometriosis for diagnostic model establishment
Li, B., Duan, H., Wang, S., & Li, Y. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.04.002 · Cited by 41
Ruiz, A., Ruiz, L. A., Colón-Caraballo, M., Torres, B., Monteiro, J. B., Bayona, M., Fazleabas, A. T., & Flores, I. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox152 · Cited by 41
miR-191 Modulates Malignant Transformation of Endometriosis Through Regulating TIMP3
Hua, F. (2015) · Medical Science Monitor · doi:10.12659/msm.893872 · Cited by 40
Stewart, L. M., Stewart, C. J. R., Spilsbury, K., Cohen, P. A., & Jordan, S. J. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.01.027 · Cited by 40
Overall Adiposity, Adipose Tissue Distribution, and Endometriosis: A Systematic Review
Backonja, U., Buck Louis, G. M., & Lauver, D. R. (2016) · Nursing Research · doi:10.1097/nnr.0000000000000146 · Cited by 39
Opportunistic salpingectomy for ovarian cancer prevention
Hanley, G. E., McAlpine, J. N., Kwon, J. S., & Mitchell, G. (2015) · Gynecologic Oncology Research and Practice · doi:10.1186/s40661-015-0014-1 · Cited by 42
Bouchard‐Fortier, G., Panzarella, T., Rosen, B. P., Chapman, W. B., & Gien, L. T. (2016) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.10.006 · Cited by 39
Ovarian Cancer Prevention in High-risk Women
Temkin, S. M., Bergstrom, J., Samimi, G., & Minasian, L. M. (2017) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000318 · Cited by 39
Endometriosis and strategies of fertility preservation: a systematic review of the literature
Calagna, G., Corte, L. D., Giampaolino, P., Maranto, M., & Perino, A. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.09.045 · Cited by 39
Association between pelvic inflammatory disease and risk of ovarian cancer: An updated meta-analysis
Piao, J., Lee, E. J., & Lee, M. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.02.002 · Cited by 38
New therapies for clear cell ovarian carcinoma
Stewart, J., Cunningham, N., & Banerjee, S. N. (2023) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2022-003704 · Cited by 38
Borrelli, G. M., Abrão, M. S., TAUBE, E. T., Darb‐Esfahani, S., Köhler, C., Chiàntera, V., & Mechsner, S. (2016) · Molecular Human Reproduction · doi:10.1093/molehr/gaw009 · Cited by 39
Hwang, H., Chung, Y., Lee, S. R., Park, H.-T., Song, J., Kim, H., Lee, D. Y., Lee, E.-J., Kim, J.-H., & Oh, S.-T. (2018) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2018.61.5.553 · Cited by 38
Gaia‐Oltean, A. I., Braicu, C., Gulei, D., Ciortea, R., Mihu, D., Roman, H., Irimie, A., & Berindan‐Neagoe, I. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9674 · Cited by 40
Murphy, M., Trabert, B. L., Yang, H., Park, Y., Brinton, L. A., Hartge, P. A., Sherman, M. E., Hollenbeck, A. R., & Wentzensen, N. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0063-2 · Cited by 38
Development of ovarian cancer after excision of endometrioma
Haraguchi, H., Koga, K., Takamura, M., Makabe, T., Sue, F., Miyashita, M., Urata, Y., Izumi, G., Harada, M., Hirata, T., et al. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.07.1077 · Cited by 36
Stewart, L. M., Spilsbury, K., Jordan, S. J., Stewart, C. J. R., Holman, C. D. J., Powell, A., Reekie, J., & Cohen, P. A. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.05.011 · Cited by 37
Gadducci, A., & Zannoni, G. F. (2020) · Anticancer Research · doi:10.21873/anticanres.14212 · Cited by 38
Fu, L., Zhang, D., Yi, N., Cao, Y., Wei, Y., Wang, W., & Li, L. (2022) · Human Cell · doi:10.1007/s13577-022-00748-8 · Cited by 37
Chenevix‐Trench, G., Kelemen, L. E., Bandera, E. V., Terry, K. L., Rossing, M. A., Brinton, L. A., Doherty, J. A., Ness, R. B., Kjær, S. K., Chang‐Claude, J., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-28 · Cited by 37
Self-citationManagement of endometriosis: Toward value-based, cost-effective, affordable care
Vercellini, P., Facchin, F., Buggio, L., Barbara, G., Berlanda, N., Frattaruolo, M. P., & Somigliana, E. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.07.011 · Cited by 36
Shafrir, A. L., Babić, A., Tamimi, R. M., ROSNER, B. A., Tworoger, S. S., & Terry, K. L. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.316 · Cited by 36
Self-citationBurghaus, S., Häberle, L., Schrauder, M. G., Heusinger, K., Thiel, F. C., Hein, A., Wachter, D. L., Strehl, J. D., Hartmann, A., Ekici, A. B., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1821-9 · Cited by 37
Self-citationArakawa, N., Kobayashi, H., Yonemoto, N., Masuishi, Y., Ino, Y., Shigetomi, H., Furukawa, N., Ohtake, N., Miyagi, Y., Hirahara, F., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165609 · Cited by 36
Endometriosis-Associated Ovarian Cancer
Barreta, A., Sarian, L. O., Ferracini, A. C., Eloy, L., Brito, A. B. C., Andrade, L. A. L. D. A., & Derchain, S. (2018) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001317 · Cited by 36
Hysterics and Heresy: Using Dialogism to Explore the Problematics of Endometriosis Diagnosis
Krebs, E., & Schoenbauer, K. V. (2019) · Health Communication · doi:10.1080/10410236.2019.1606136 · Cited by 36
Hurwitz, L. M., Townsend, M. K., Jordan, S. J., Patel, A. V., Teras, L. R., Lacey, J. V., Doherty, J. A., Harris, H. R., Goodman, M. T., Shvetsov, Y. B., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01900 · Cited by 36
Self-citationQin, B., Moorman, P. G., Alberg, A. J., Barnholtz‐Sloan, J. S., Bondy, M. L., Coté, M. L., Funkhouser, E. M., Peters, E. S., Schwartz, A. G., Terry, P., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515004882 · Cited by 35
Self-citationEdwards, R. P., Huang, X., & Vlad, A. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.1002732 · Cited by 35
Three-Dimensional Biofabrication Models of Endometriosis and the Endometriotic Microenvironment
Wendel, J. R. H., Wang, X., Smith, L. J., & Hawkins, S. M. (2020) · Biomedicines · doi:10.3390/biomedicines8110525 · Cited by 35
Cytotoxic T-Cells in Peripheral Blood in Women with Endometriosis
Slabe, N., Meden‐Vrtovec, H., Verdenik, I., Pogačnik, R. K., & Ihan, A. (2013) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0033-1350702 · Cited by 35
Executive Summary of the Ovarian Cancer Evidence Review Conference
Burke, W. M., Barkley, J., Barrows, E., Brooks, R. A., Gecsi, K. S., Huber-Keener, K. J., Jeudy, M., Mei, S., O’Hara, J. S., & Chelmow, D. P. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005211 · Cited by 34
Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention Programs
Sowamber, R., Lukey, A., Huntsman, D. D., & Hanley, G. E. (2023) · Current Oncology · doi:10.3390/curroncol30120741 · Cited by 34
Self-citationJones, N., Schulkin, J. A., Urban, R. R., Wright, J. D., Burke, W. M., Hou, J. Y., McElwain, C.-A., & Tergas, A. I. (2016) · Cancer Investigation · doi:10.1080/07357907.2016.1242597 · Cited by 34
Hermens, M., van Altena, A. M., van der Aa, M. A., Bulten, J., van Vliet, H. A. A. M., Siebers, A. G., & Bekkers, R. L. M. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.08.056 · Cited by 34
PET/CT Variants and Pitfalls in Gynecological Cancers
Dejanović, D., Hansen, N. L., & Loft, A. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2021.06.006 · Cited by 34
Molecular Pathogenesis of Ovarian Clear Cell Carcinoma
Gounaris, I., & Brenton, J. D. (2015) · Future Oncology · doi:10.2217/fon.15.45 · Cited by 34
Babić, A., Cramer, D. W., Kelemen, L. E., Köbel, M., Steed, H. L., Webb, P. M., Johnatty, S. E., DeFazio, A., Lambrechts, D., Goodman, M. T., et al. (2017) · Cancer Causes & Control · doi:10.1007/s10552-016-0841-3 · Cited by 33
Self-citationOvarian cancer: density equalizing mapping of the global research architecture
Brüggmann, D., Pulch, K., Klingelhöfer, D., Pearce, C. L., & Groneberg, D. A. (2017) · International Journal of Health Geographics · doi:10.1186/s12942-016-0076-2 · Cited by 34
Self-citationYachida, N., Yoshihara, K., Suda, K., Nakaoka, H., Ueda, H., Sugino, K., Yamaguchi, M., Mori, Y., Yamawaki, K., Tamura, R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71273-7 · Cited by 33
Toyokuni, S., Kong, Y., Cheng, Z., Sato, K., Hayashi, S., Ito, F., Jiang, L., Yanatori, I., Okazaki, Y., & Akatsuka, S. (2020) · Cancers · doi:10.3390/cancers12113320 · Cited by 33
A Systematic Review of Atypical Endometriosis-Associated Biomarkers
Bartiromo, L., Schimberni, M., Villanacci, R., Mangili, G., Ferrari, S. M., Ottolina, J., Salmeri, N., Dolci, C., Tandoi, I., & Candiani, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084425 · Cited by 33
Okamoto, A., Sehouli, J., Yanaihara, N., Hirata, Y., Braicu, E. I., Kim, B., Takakura, S., Saito, M., Yanagida, S., Takenaka, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116977 · Cited by 33
Improvement in 5-Year Survival Rates for the Most Common Types of Cancer, 1975-2012
Epidemiology Working Group Steering Committee, O. C. A. C. M. O. T. E. S., Doherty, J. A., Jensen, A., Kelemen, L. E., Pearce, C. L., Poole, E., Schildkraut, J. M., Terry, K. L., Tworoger, S. S., Webb, P. M., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx114 · Cited by 32
Self-citationClear differences in ovarian cancer incidence and trends by ethnicity among Asian Americans
Lee, A. W., Navajas, E. E., & Liu, L. (2019) · Cancer Epidemiology · doi:10.1016/j.canep.2019.06.005 · Cited by 32
Self-citationBiological significance of KRAS mutant allele expression in ovarian endometriosis
Yachida, N., Yoshihara, K., Suda, K., Nakaoka, H., Ueda, H., Sugino, K., Yamaguchi, M., Mori, Y., Yamawaki, K., Tamura, R., et al. (2021) · Cancer Science · doi:10.1111/cas.14871 · Cited by 32
Predictive factors for the presence of malignant transformation of pelvic endometriosis
Kadan, Y., Fiascone, S. J., McCourt, C. K., Raker, C., Granai, C. O., Steinhoff, M. M., & Moore, R. G. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.11.029 · Cited by 32
Serum microRNAs in clear cell carcinoma of the ovary
Chao, A., Lai, C., Chen, H., Lin, C., Tsai, C.-L., Tang, Y., Huang, H.-J., Lin, C.-T., Chen, M., Huang, K.-G., et al. (2014) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2014.07.005 · Cited by 32
Environmental (nongenetic) factors in gynecological cancers: update and future perspectives
Webb, P. M. (2015) · Future Oncology · doi:10.2217/fon.14.142 · Cited by 32
Self-citationMa, F., Qiang, J.-W., Zhang, G., Li, H., Cai, S., & Rao, Y. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0251-x · Cited by 32
Kuo, H.-H., Huang, C.-Y., Ueng, S., Huang, K., Lee, C., & Yen, C. (2017) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2015.09.009 · Cited by 32
Taniguchi, F., Harada, T., Kobayashi, H., Hayashi, K., Momoeda, M., & Terakawa, N. (2014) · Gynecologic and Obstetric Investigation · doi:10.1159/000357819 · Cited by 31
Ovarian carcinoma associated with endometriosis
Boyraz, G., Selçuk, İ., Yazıcıoğlu, A., & Tuncer, Z. S. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.06.001 · Cited by 31
Zanello, M., Borghese, G., Manzara, F., Esposti, E. D., Moro, E., Raimondo, D., Abdullahi, L. O., Arena, A., Terzano, P., Meriggiola, M. C., et al. (2019) · Medicina · doi:10.3390/medicina55080477 · Cited by 31
Metadata
- Authors
- Pearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., Chang-Claude, J., Hein, R., Lurie, G., Wilkens, L. R., Carney, M. E., Goodman, M. T., Moysich, K., Kjaer, S. K., Hogdall, E., Jensen, A., Goode, E. L., Fridley, B. L., Larson, M. C., Schildkraut, J. M., Palmieri, R. T., Cramer, D. W., Terry, K. L., Vitonis, A. F., Titus, L. J., Ziogas, A., Brewster, W., Anton-Culver, H., Gentry-Maharaj, A., Ramus, S. J., Anderson, A. R., Brueggmann, D., Fasching, P. A., Gayther, S. A., Huntsman, D. G., Menon, U., Ness, R. B., Pike, M. C., Risch, H., Wu, A. H., & Berchuck, A.
- Affiliations
- University of Southern California (US)
- Fred Hutch Cancer Center (US)
- Georgetown University Medical Center (US)
- QIMR Berghofer Medical Research Institute (AU)
- German Cancer Research Center (DE)
- University of Hawaiʻi at Mānoa (US)
- Roswell Park Comprehensive Cancer Center (US)
- Danish Cancer Society (DK)
- Mayo Clinic (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Dartmouth College (US)
- University of California, Irvine (US)
- University of North Carolina at Chapel Hill (US)
- University College London (GB)
- University of California, Los Angeles (US)
- Yale University (US)
- Corresponding author
- Pearce, Celeste Leigh
- ORCID
- Pearce, Celeste Leigh
- Lee, Alice
- Near, Aimee M
- Webb, Penelope M
- Nagle, Christina M
- Doherty, Jennifer A
- Wicklund, Kristine G
- Wilkens, Lynne R
- Goodman, Marc T
- Moysich, Kirsten
- Jensen, Allan
- Goode, Ellen L
- Fridley, Brooke L
- Larson, Melissa C
- Schildkraut, Joellen M
- Cramer, Daniel W
- Terry, Kathryn L
- Titus, Linda J
- Ziogas, Argyrios
- Brewster, Wendy
- Ramus, Susan J
- Fasching, Peter A
- Gayther, Simon A
- Menon, Usha
- Pike, Malcolm C
- Risch, Harvey
- Wu, Anna H
- Berchuck, Andrew
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 13
- Issue
- 4
- Pages
- 385-394
- ISSN
- 1470-2045 (ISSN-L)
- PMC
- PMC3664011
- OpenAlex
- W2125681453
- Cited by
- 939
- References
- 43
- Citations by year
- 2026: 47 · 2025: 53 · 2024: 46 · 2023: 64 · 2022: 44 · 2021: 84 · 2020: 88 · 2019: 77 · 2018: 71 · 2017: 83 · 2016: 68 · 2015: 65 · 2014: 55 · 2013: 68 · 2012: 26
- FWCI
- 79.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet Oncology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- California Breast Cancer Research Program (0001389V20170, 2110200)
- Seventh Framework Programme (HEALTH-F2-2009-223175)
- University of South China
- National Institutes of Health (5R01 CA074850, CA14089, CA17054, CA58860, CA61132, CA92044, N01 CN67001, N01 PC35137, N01 PC67010, P50 CA105009, P50 CA136393, PSA 042205, R01 CA112523, R01 CA122443, R01 CA126841, R01 CA136891, R01 CA54419, R01 CA58598, R01 CA61107, R01 CA76016, R01 CA87538, R01 CA95023, R03 CA113148)
- Medical Research and Materiel Command (DAMD 170110729, DAMD17-02-1-0669, W81XWH0610220, W81XWH1010280)
- Oak Foundation
- Lon V. Smith Foundation (LVS 39420)
- California Department of Public Health (050E8709)
- Roswell Park Alliance Foundation, Roswell Park Cancer Institute
- Kræftens Bekæmpelse
- Deutsches Krebsforschungszentrum
- National Health and Medical Research Council (199600)
- Cancer Council Tasmania
- American University of Sharjah
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- endometriosis, ovarian cancer, histological subtypes, ovarian clear cell carcinoma, low-grade serous ovarian cancer, endometrioid ovarian cancer, mucinous ovarian carcinoma, high-grade serous ovarian cancer, borderline ovarian tumors, cancer risk factors, oral contraceptive use, parity, tumor stage and grade, Ovarian Cancer Association Consortium
- MeSH terms
- Aged, Aged, 80 and over, Endometriosis, Ethnicity, Female, Humans, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Ovarian Neoplasms, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
